Lupin Limited
LUPIN
Hisse Senetlerindeki Sıralama
#2107
Lupin Limited is a pharmaceutical firm dedicated to the creation,... Lupin Limited is a pharmaceutical firm dedicated to the creation, manufacturing, commercialization, and distribution of a wide array of branded and generic medications, biotechnology items, and active pharmaceutical ingredients (APIs). Its comprehensive product portfolio addresses diverse therapeutic categories, including cardiovascular health, diabetes management, asthma, pediatric care, central nervous system disorders, gastrointestinal issues, anti-infectives, nonsteroidal anti-inflammatory drug (NSAID) therapy, respiratory ailments, women's health, and anti-tuberculosis treatments. Beyond its primary offerings, Lupin also supplies biosimilars and over-the-counter (OTC) medicines, alongside specialized pharmaceutical products. The company actively pursues drug discovery and development initiatives focused on oncology, immunology, and metabolic disorders, complementing these efforts with bio-clinical research. Lupin Limited maintains an extensive operational network comprising 18 laboratories, 280 LupiMitra collection centers, and 450 pick-up points. Its global presence extends across numerous countries, such as India, the United States, the United Kingdom, South Africa, Australia, the Philippines, Germany, the Netherlands, Mexico, and Brazil. Originally named Lupin Chemicals Limited, the company adopted its current identity, Lupin Limited, in 2001 following its merger with Lupin Laboratories Limited. Established in 1968, Lupin Limited is based in Mumbai, India.
Hisse Fiyatı
$21.43
Piyasa Değeri
$9.80B
Değişim (1 gün)
0.14%
Değişim (1 yıl)
-2.88%
Ülke
IN
Ticaret Lupin Limited (LUPIN)
Kategori
Healthcare
Lupin Limited (LUPIN) için kazanç
Jun 2026 itibarıyla kazanç TTM: $824.86M
Lupin Limited şirketinin en son finansal raporlarına göre, mevcut kazancı $824.86M'dir. 2024 yılında şirket $290.50M kazanç elde etti, bu 2023 yılındaki $87.18M kazanca göre önceki yıla göre artış. Bu sayfada gösterilen kazanç, faiz ve vergiler öncesi kazançtır; yani EBIT.
Lupin Limited için kazanç geçmişi 2004 - 2026
Her yılın sonundaki kazanç
| Yıl | Kazanç | Değiştir |
|---|---|---|
| 2026 (TTM) | $824.86M | 75.71% |
| 2025 | $469.45M | 61.60% |
| 2024 | $290.50M | 233.20% |
| 2023 | $87.18M | -148.23% |
| 2022 | $-180.77M | -178.93% |
| 2021 | $229.01M | 127.84% |
| 2020 | $100.52M | -50.46% |
| 2019 | $202.90M | 141.60% |
| 2018 | $83.98M | -84.63% |
| 2017 | $546.37M | 8.74% |
| 2016 | $502.47M | -8.18% |
| 2015 | $547.26M | -3.94% |
| 2014 | $569.71M | 60.84% |
| 2013 | $354.21M | 50.17% |
| 2012 | $235.88M | 5.71% |
| 2011 | $223.13M | 19.92% |
| 2010 | $186.07M | 55.87% |
| 2009 | $119.38M | -11.57% |
| 2008 | $135.00M | 43.62% |
| 2007 | $93.99M | 85.65% |
| 2006 | $50.63M | 132.81% |
| 2005 | $21.75M | -50.60% |
| 2004 | $44.02M | 0.00% |
Benzer şirketler veya rakipler için kazanç
| Şirket | Kazanç | Kazanç Farkı | Ülke |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| $1.76B | 113.92% |
IN
|
